Financhill
Back

Akebia Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
39

AKBA
Akebia Therapeutics

Last Price:
$1.84
Seasonality Move:
7.91%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
39
Akebia Therapeutics (AKBA) is a Sell

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.84. The Score for AKBA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • AKBA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.84
    The current trend is relatively stagnant and AKBA is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 46.96 Sell
Chaikin Money Flow: 2456900 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.81 - 2.03) Sell
Bollinger Bands (100): (1.31 - 1.85) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.44 Sell
Chaikin Money Flow: 514099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.67) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.84 Sell
20-day SMA: 1.95 Sell
50-day SMA: 1.79 Buy
200-day SMA: 1.45 Buy
8-day EMA: 1.85 Sell
20-day EMA: 1.88 Sell
50-day EMA: 1.79 Buy
200-day EMA: 1.5 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.54 Sell
20-day SMA: 0.57 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.88 Sell
8-day EMA: 0.54 Sell
20-day EMA: 0.57 Sell
50-day EMA: 0.64 Sell
200-day EMA: 4.7 Sell

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):